D. Weilenmann

发表

A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trial.

P. Jüni, S. Windecker, M. Valgimigli, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment-elevation myocardial infarction: A subgroup analysis of the BIOSTEMI randomized trial.

S. Windecker, M. Valgimigli, O. Muller, 2021, International journal of cardiology.

Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute ST-Segment Elevation Myocardial Infarction: Insights From the 2-Year Follow-Up of the BIOSCIENCE Trial.

S. Cook, S. Windecker, O. Muller, 2016, JACC. Cardiovascular interventions.

Heart Failure/Transplantation Combining Low-Intensity and Maximal Exercise Test Results Improves Prognostic Prediction in Chronic Heart Failure

H. Rickli, E. Oechslin, D. Weilenmann, 2003 .

Combining low-intensity and maximal exercise test results improves prognostic prediction in chronic heart failure.

H. Brunner-La Rocca, H. Rickli, E. Oechslin, 2003, Journal of the American College of Cardiology.

Oxygen uptake kinetics during low level exercise in patients with heart failure: relation to neurohormones, peak oxygen consumption, and clinical findings

F. Follath, H. Rickli, H. Rocca, 1999, Heart.

Prognostic significance of oxygen uptake kinetics during low level exercise in patients with heart failure.

F. Follath, H. Brunner-La Rocca, F Follath, 1999, The American journal of cardiology.

Chronic total occlusion percutaneous coronary intervention in Latin America

J. Mangione, C. Bezerra, C. Gottschall, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of Patient and Lesion Complexity on Long-Term Outcomes Following Coronary Revascularization With New-Generation Drug-Eluting Stents.

P. Jüni, S. Cook, S. Windecker, 2017, The American journal of cardiology.

Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial

S. Winkler, M. Böhm, P. Erne, 2018, The Lancet.

Clinical Characteristics, Sex Hormones, and Long‐Term Follow‐Up in Swiss Postmenopausal Women Presenting With Takotsubo Cardiomyopathy

H. Rickli, D. Weilenmann, R. Brenner, 2012, Clinical cardiology.

Coronary and structural heart interventions in Switzerland 2018.

S. Cook, R. Jeger, R. Twerenbold, 2020, Swiss medical weekly.

Plasma levels of enalaprilat in chronic therapy of heart failure: relationship to adverse events.

F. Follath, H. Brunner-La Rocca, F. Maly, 1999, The Journal of pharmacology and experimental therapeutics.

Within-patient comparison of effects of different dosages of enalapril on functional capacity and neurohormone levels in patients with chronic heart failure.

F. Follath, H. Brunner-La Rocca, F. Maly, 1999, American heart journal.

Integration of B-type natriuretic peptide levels with clinical data and exercise testing for predicting coronary artery disease.

H. Rickli, W. Riesen, F. Duru, 2006, The American journal of cardiology.

Non-invasive assessment prior to invasive coronary angiography in routine clinical practice in Switzerland – Is it according to the guidelines?

H. Rickli, D. Weilenmann, M. Maeder, 2019, PloS one.

Drug-coated balloon versus drug-eluting stent in small coronary artery lesions: angiographic analysis from the BASKET-SMALL 2 trial

M. Ohlow, R. Jeger, J. Wöhrle, 2020, Clinical Research in Cardiology.

Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial

M. Ohlow, R. Jeger, J. Wöhrle, 2022, Clinical Research in Cardiology.

Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 Trial.

M. Ohlow, R. Jeger, J. Wöhrle, 2021, JACC. Cardiovascular interventions.

Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial

S. Winkler, P. Erne, P. Buser, 2020, The Lancet.

Individualised PPI prescription in patients on combination antiplatelet therapy and upper gastrointestinal events after percutaneous coronary intervention: a cohort study

J. Borovička, S. Haile, D. Weilenmann, 2012, Wiener Medizinische Wochenschrift.

[Myocardial infarction during attempted suicide].

D. Weilenmann, M. Diethelm, D. Tapernoux, 2009, Deutsche medizinische Wochenschrift.

B-type natriuretic peptide kinetics and cardiopulmonary exercise testing in heart failure.

J. Myers, H. Rickli, W. Riesen, 2007, International journal of cardiology.

Atrioventricular block after administration of atropine in patients following cardiac transplantation.

F. Follath, H. Brunner-La Rocca, D. Weilenmann, 1997, Transplantation.

Long-Term Data from the Swiss Pulmonary Hypertension Registry

M. Schwerzmann, R. Speich, T. Rochat, 2014, Respiration.

Multicentre observational screening survey for the detection of CTEPH following pulmonary embolism

S. Ulrich, H. Stricker, D. Stolz, 2018, European Respiratory Journal.

Importance of Ventricular Rate After Mode Switching During Low Intensity Exercise as Assessed by Clinical Symptoms and Ventilatory Gas Exchange

H. Rickli, F. Duru, R. Candinas, 2000, Pacing and clinical electrophysiology : PACE.

Invasive Hemodynamic Staging Classification of Cardiac Damage in Patients With Aortic Stenosis Undergoing Valve Replacement.

M. Taramasso, F. Maisano, P. Haager, 2020, The Canadian journal of cardiology.

Spontaneous Coronary Artery Dissection

P. Haager, H. Rickli, D. Weilenmann, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Use of optical coherence tomography in acute clinical settings.

D. Weilenmann, René Vollenbroich, M. Maeder, 2014, International journal of cardiology.

Impact of a volume challenge on haemodynamics and prognosis in patients with severe aortic stenosis

P. Haager, H. Rickli, D. Weilenmann, 2020, ESC heart failure.

Haemodynamic mechanisms and long‐term prognostic impact of pulmonary hypertension in patients with severe aortic stenosis undergoing valve replacement

M. Taramasso, F. Maisano, P. Haager, 2018, European journal of heart failure.

Impact of the new pulmonary hypertension definition on long‐term mortality in patients with severe aortic stenosis undergoing valve replacement

P. Haager, H. Rickli, T. Neumann, 2021, Clinical cardiology.

Moderator band connections: an unusual route in retrograde chronic total occlusion procedure: moderator band connections as options to right coronary artery chronic total occlusion

S. Sumitsuji, D. Weilenmann, M. Boukhris, 2019, Vessel Plus.

Hemodynamics Prior to Valve Replacement for Severe Aortic Stenosis and Pulmonary Hypertension during Long-Term Follow-Up

P. Haager, H. Rickli, D. Weilenmann, 2021, Journal of clinical medicine.

Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial

Marco Roffi, Peter Jüni, Thomas Pilgrim, 2014, The Lancet.

Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents for Primary PCI: A Subgroup Analysis of the BIOSTEMI Randomized Trial.

S. Windecker, M. Valgimigli, O. Muller, 2020, JACC: Cardiovascular Interventions.

Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: a substudy of the BIOSCIENCE trial.

P. Jüni, S. Cook, S. Windecker, 2016, EuroIntervention.

[A Rare Cause for Transient Aphasia after Conorary Angiography].

T. Hundsberger, D. Weilenmann, C. Schilling, 2018, Praxis.

Switzerland: coronary and structural heart interventions from 2010 to 2015.

P. Wenaweser, S. Cook, M. Roffi, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Influence of Acute Exposure to High Altitude and Hypoxemia on Ventricular Stimulation Thresholds in Pacemaker Patients

F. Duru, R. Candinas, D. Weilenmann, 2000, Pacing and clinical electrophysiology : PACE.

Annulus paradoxus

H. Rickli, D. Weilenmann, N. Ehl, 2012 .

An unusual cause of pulmonary hypertension in the elderly

H. Rickli, D. Weilenmann, N. Ehl, 2019, Cardiovascular Medicine.

Severely worsening dyspnea after initiation of macitentan therapy for pulmonary arterial hypertension.

D. Weilenmann, M. Maeder, Rebekka Kleiner, 2016, International journal of cardiology.

Noninvasive evaluation of pulmonary capillary wedge pressure by BP response to the Valsalva maneuver.

F. Follath, H. Brunner-La Rocca, H. Rickli, 2002, Chest.

Is blood pressure response to the Valsalva maneuver related to neurohormones, exercise capacity, and clinical findings in heart failure?

F. Follath, H. Brunner-La Rocca, H. Rickli, 1999, Chest.

Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial

F. Eberli, S. Cook, S. Windecker, 2018, The Lancet.

Congestive heart failure related to antifungal therapy with itraconazole.

D. Weilenmann, René Vollenbroich, M. Maeder, 2014, International journal of cardiology.

ATROPINE OFTEN RESULTS IN COMPLETE ATRIOVENTRICULAR BLOCK OR SINUS ARREST AFTER CARDIAC TRANSPLANTATION: AN UNPREDICTABLE AND DOSE-INDEPENDENT PHENOMENON

H. Rickli, H. Rocca, D. Weilenmann, 2004, Transplantation.

Constrictive pericarditis presenting as a large mediastinal mass causing functional tricuspid and pulmonary stenosis.

V. Falk, S. Sündermann, H. Rickli, 2011, Circulation.

Images in Cardiovascular Medicine Constrictive Pericarditis Presenting as a Large Mediastinal Mass Causing Functional Tricuspid and Pulmonary Stenosis

V. Falk, H. Rickli, D. Weilenmann, 2011 .

Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy.

M. Pfisterer, T. Fehr, T. Dieterle, 2012, American heart journal.

Drug‐coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET‐SMALL 2

M. Ohlow, R. Jeger, J. Wöhrle, 2018, Clinical cardiology.

Pulmonary hypertension associated with left-sided heart disease.

D. Weilenmann, O. Schoch, L. Joerg, 2017, Swiss medical weekly.

Randomized comparison of biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for percutaneous coronary revascularization: rationale and design of the BIOSCIENCE trial.

S. Cook, S. Windecker, O. Muller, 2014, American heart journal.

Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial

M. Zwahlen, S. Windecker, M. Valgimigli, 2019, The Lancet.

Complex primary percutaneous coronary intervention with ultrathin‐strut biodegradable versus thin‐strut durable polymer drug‐eluting stents in patients with ST‐segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI randomized trial

S. Windecker, D. Heg, T. Pilgrim, 2023, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial.

S. Cook, S. Windecker, O. Muller, 2019, Circulation. Cardiovascular interventions.

Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI: Final 2-Year Outcomes of the BIOSTEMI Trial.

S. Windecker, M. Valgimigli, O. Muller, 2021, JACC. Cardiovascular interventions.

Activity‐Controlled Circadian Base Rate

K. Bloch, Euljoon Park, D. Weilenmann, 1998, Pacing and clinical electrophysiology : PACE.

Trends in Coronary and Structural Heart Interventions in Switzerland over the Last 16 Years and Impact of COVID-19: Insights from the National Swiss PCI Survey

L. Räber, F. Nietlispach, O. Muller, 2022, Journal of clinical medicine.

Coronary and structural heart interventions in Switzerland 2019.

L. Räber, S. Cook, F. Nietlispach, 2021, Swiss medical weekly.

The SWISS PCI Survey – coronary and structural heart interventions in Switzerland 2020

F. Nietlispach, O. Muller, R. Jeger, 2022, Cardiovascular Medicine.

Ultrathin-Strut versus Thin-Strut Drug-Eluting Stents for Multi- and Single-Stent Lesions: A Lesion-Level Subgroup Analysis of Two Randomized Trials.

S. Windecker, D. Heg, J. Häner, 2023, American heart journal.

Clinical Outcomes According to Diabetic Status in Patients Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: Prespecified Subgroup Analysis of the BIOSCIENCE Trial

L. Räber, P. Wenaweser, S. Cook, 2015, Circulation. Cardiovascular interventions.

Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial.

F. Eberli, D. Conen, M. Pfisterer, 2015, Circulation.

Crystalline sirolimus-coated balloon (cSCB) angioplasty in an all-comers, patient population with stable and unstable coronary artery disease including chronic total occlusions: rationale, methodology and design of the SCORE trial

Wan Azman Wan Ahmad, J. Wöhrle, M. Waliszewski, 2023, BMC Cardiovascular Disorders.

Five‐Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus‐Eluting Stents Versus Durable Polymer Everolimus‐Eluting Stents

S. Cook, S. Windecker, M. Valgimigli, 2019, Journal of the American Heart Association.

Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction.

P. Wenaweser, S. Cook, S. Windecker, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Five-year outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with acute coronary syndrome: A subgroup analysis of the BIOSCIENCE trial.

S. Cook, S. Windecker, M. Valgimigli, 2021, Cardiovascular revascularization medicine : including molecular interventions.

Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial

M. Ohlow, R. Jeger, J. Wöhrle, 2022, Circulation. Cardiovascular interventions.

Gender differences in percutaneous coronary intervention for chronic total occlusions from the ERCTO study

J. Wójcik, N. Bozinovic, C. Di Mario, 2023, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Ultrathin Strut Biodegradable Polymer Sirolimus‐Eluting Stent Versus Durable‐Polymer Everolimus‐Eluting Stent for Percutaneous Coronary Revascularization: 2‐Year Results of the BIOSCIENCE Trial

F. Eberli, S. Cook, S. Windecker, 2016, Journal of the American Heart Association.

Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II

F. Eberli, D. Conen, M. Pfisterer, 2019, PloS one.

Estimated glomerular filtration rate, haemodynamics, and mortality in patients with aortic stenosis

P. Haager, H. Rickli, D. Weilenmann, 2023, European journal of clinical investigation.

Clinical Evaluation of a Pacemaker Algorithm That Adjusts the Pacing Rate During Sleep Using Activity Variance

K. Bloch, F. Duru, R. Candinas, 2000, Pacing and clinical electrophysiology : PACE.

Swiss recommendations for non-anaesthesiologist administered procedural sedation and analgesia in adults

S. Krayer, P. Bauerfeind, D. Weilenmann, 2019, Cardiovascular Medicine.

Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 Trial

M. Ohlow, R. Jeger, J. Wöhrle, 2023, Journal of cardiovascular development and disease.

Long-term Efficacy and Safety of Biodegradable-polymer Biolimus-eluting Stents Main Results of the Basel Stent Kosten-effektivitäts Trial–prospective Validation Examination Ii (basket-prove Ii), a Randomized, Controlled Noninferiority 2-year Outcome Trial Kaiser Et Al Efficacy and Safety of Biodegra

F. Eberli, D. Conen, M. Pfisterer, 2022 .

revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial

F. Eberli, S. Cook, S. Windecker, 2022 .

Systemic blood pressure in severe aortic stenosis: Haemodynamic correlates and long‐term prognostic impact

P. Haager, H. Rickli, D. Weilenmann, 2022, ESC heart failure.

Pulmonary hypertension in stiff left atrial syndrome: pathogenesis and treatment in one

D. Weilenmann, M. Maeder, Reto Nägele, 2017, ESC heart failure.

Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial

D. Heg, T. Pilgrim, S. Losdat, 2023, The Lancet.

L. Räber, P. Wenaweser, S. Cook, 2015, Circulation. Cardiovascular interventions.

S. Cook, S. Windecker, O. Muller, 2014, American heart journal.

Relative frequency of functional sympathetic and parasympathetic reinnervation after heart transplantation.

F. Follath, H. Brunner-La Rocca, D. Weilenmann, 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Pulmonary and systemic hemodynamics in patients with hyperthyroidism.

S. Bilz, D. Weilenmann, R. Brenner, 2023, The American journal of medicine.

Safety and Efficacy of Drug-Coated Balloons Versus Drug-Eluting Stents in Acute Coronary Syndromes: A Prespecified Analysis of BASKET-SMALL 2

M. Ohlow, R. Jeger, J. Wöhrle, 2022, Circulation. Cardiovascular interventions.

S. Cook, S. Windecker, O. Muller, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.